デフォルト表紙
市場調査レポート
商品コード
1009352

デジタルPCR市場の成長機会・成長予測 (2021-2028年):技術・製品タイプ・用途・エンドユーザー・地域別

Digital PCR Market by Technologies, Product Type, Application, and End User : Global Opportunity Analysis and Industry Forecast, 2021-2028

出版日: | 発行: Allied Market Research | ページ情報: 英文 249 Pages | 納期: 2-3営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=110.49円
デジタルPCR市場の成長機会・成長予測 (2021-2028年):技術・製品タイプ・用途・エンドユーザー・地域別
出版日: 2021年04月01日
発行: Allied Market Research
ページ情報: 英文 249 Pages
納期: 2-3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界のデジタルPCRの市場規模は予測期間中9.1%のCAGRで推移し、2020年の5億880万米ドルから、2028年には11億3990万米ドルの規模に成長すると予測されています。

感染症の有病率の上昇、個別化医療の認知度および受容度の向上、技術の進歩などの要因が同市場の成長を推進しています。また、R&Dのための資金調達の増加がさらなる市場成長の機会を示すと予測されています。一方で、デジタルPCRデバイスの高さや償還上の課題が市場のさらなる成長を抑制すると予測されています。

当レポートでは、世界のデジタルPCRの市場を調査し、市場の定義と概要、新型コロナウイルス感染症 (COVID-19) およびその他の市場影響因子の分析、市場規模の推移・予測、技術・製品タイプ・用途・エンドユーザー・地域/主要国など各種区分別の内訳、競合環境、主要企業のプロファイルなどをまとめています。

第1章 イントロダクション

第2章 エグゼクティブサマリー

第3章 市場概要

  • 市場の定義と範囲
  • 主な調査結果
  • ポーターのファイブフォース分析
  • 主要企業の位置付け
  • 市場力学
    • 促進要因
    • 抑制要因
    • 市場機会
  • NGS技術の影響
  • COVID-19:影響分析

第4章 市場分析・予測:技術別

  • ドロップレットデジタルPCR
  • チップベースのデジタルPCR
  • BEAMing デジタルPCR
    • 主要動向・成長要因・成長機会
    • 市場規模・予測
    • 市場分析:国別

第5章 市場分析・予測:製品タイプ別

  • 消耗品・試薬
  • デジタルPCRシステム
  • ソフトウェア・サービス
    • 市場規模・予測
    • 市場分析:国別

第6章 市場分析・予測:用途別

  • 研究
  • 臨床診断
  • フォレンジック・その他
    • 市場規模・予測
    • 市場分析:国別

第7章 市場分析・予測:エンドユーザー別

  • 臨床診断ラボ
  • 製薬・バイオテクノロジー産業
  • 大学・その他の機関
    • 市場規模・予測
    • 市場分析:国別

第8章 市場分析・予測:地域・主要国別

  • 北米
  • 欧州
  • アジア太平洋
  • ラテンアメリカ・中東・アフリカ
    • 主要動向・成長機会
    • 市場分析:国別
    • 市場分析:技術別
    • 市場分析:製品タイプ別
    • 市場分析:用途別
    • 市場分析:エンドユーザー別

第9章 企業プロファイル

  • BASEBIO AG
  • BIO-RAD LABORATORIES, INC.
  • COMBINATI, INC.
  • FLUIDIGM CORPORATION
  • JN MEDSYS
  • MERCK KGAA
  • QIAGEN N.V.
  • SYSMEX CORPORATION
  • STILLA TECHNOLOGIES
  • THERMO FISHER SCIENTIFIC, INC.
図表

LIST OF TABLES

  • TABLE 01.KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 02.KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 03.GLOBAL DIGITAL POLYMERASE CHAIN REACTION MARKET, BY TECHNOLOGY, 2020-2028 ($MILLION)
  • TABLE 04.GLOBAL POLYMERASE CHAIN REACTION TECHNOLOGIES MARKET, 2016-2023 ($MILLION)
  • TABLE 05.DROPLET DIGITAL POLYMERASE CHAIN REACTION MARKET, BY REGION, 2020-2028 ($MILLION)
  • TABLE 06.CHIP BASED DIGITAL PCR MARKET, BY REGION, 2020-2028 ($MILLION)
  • TABLE 07.BEAMING PCR MARKET, BY REGION, 2020-2028 ($MILLION)
  • TABLE 08.GLOBAL DIGITAL POLYMERASE CHAIN REACTION MARKET, BY PRODUCT TYPE, 2020-2028 ($MILLION)
  • TABLE 09.DIGITAL POLYMERASE CHAIN REACTION MARKET FOR CONSUMABLES & REAGENTS, BY REGION, 2020-2028 ($MILLION)
  • TABLE 10.DIGITAL PCR SYSTEMS MARKET, BY REGION, 2020-2028 ($MILLION)
  • TABLE 11.DIGITAL POLYMERASE CHAIN REACTION MARKET FOR SOFTWARE & SERVICES, BY REGION, 2020-2028 ($MILLION)
  • TABLE 12.GLOBAL DIGITAL POLYMERASE CHAIN REACTION MARKET, BY APPLICATION, 2020-2028 ($MILLION)
  • TABLE 13.DIGITAL POLYMERASE CHAIN REACTION MARKET FOR RESEARCH, BY REGION, 2020-2028 ($MILLION)
  • TABLE 14.DIGITAL POLYMERASE CHAIN REACTION MARKET FOR CLINICAL DIAGNOSTICS, BY REGION, 2020-2028 ($MILLION)
  • TABLE 15.DIGITAL POLYMERASE CHAIN REACTION MARKET FOR FORENSIC & OTHERS, BY REGION, 2020-2028 ($MILLION)
  • TABLE 16.GLOBAL DIGITAL POLYMERASE CHAIN REACTION MARKET, BY END USER, 2020-2028 ($MILLION)
  • TABLE 17.DIGITAL POLYMERASE CHAIN REACTION MARKET FOR CLINICAL DIAGNOSTIC LABORATORIES, BY REGION, 2020-2028 ($MILLION)
  • TABLE 18.DIGITAL POLYMERASE CHAIN REACTION MARKET FOR PHARMACEUTICALS & BIOTECHNOLOGY INDUSTRIES, BY REGION, 2020-2028 ($MILLION)
  • TABLE 19.DIGITAL POLYMERASE CHAIN REACTION MARKET FOR UNIVERSITIES & OTHER ORGANIZATIONS, BY REGION, 2020-2028 ($MILLION)
  • TABLE 20.DIGITAL PCR MARKET REVENUE, BY REGION, 2020-2028($MILLION)
  • TABLE 21.NORTH AMERICA DIGITAL PCR MARKET, BY COUNTRY, 2020-2028($MILLION)
  • TABLE 22.U.S. DIGITAL PCR MARKET, BY TECHNOLOGY, 2020-2028($MILLION)
  • TABLE 23.U.S. DIGITAL PCR MARKET, BY PRODUCT TYPE, 2020-2028($MILLION)
  • TABLE 24.U.S. DIGITAL PCR MARKET, BY APPLICATION, 2020-2028($MILLION)
  • TABLE 25.U.S. DIGITAL PCR MARKET, BY END USER, 2020-2028($MILLION)
  • TABLE 26.CANADA DIGITAL PCR MARKET, BY TECHNOLOGY, 2020-2028($MILLION)
  • TABLE 27.CANADA DIGITAL PCR MARKET, BY PRODUCT TYPE, 2020-2028($MILLION)
  • TABLE 28.CANADA DIGITAL PCR MARKET, BY APPLICATION, 2020-2028($MILLION)
  • TABLE 29.CANADA DIGITAL PCR MARKET, BY END USER, 2020-2028($MILLION)
  • TABLE 30.MEXICO DIGITAL PCR MARKET, BY TECHNOLOGY, 2020-2028($MILLION)
  • TABLE 31.MEXICO DIGITAL PCR MARKET, BY PRODUCT TYPE, 2020-2028($MILLION)
  • TABLE 32.MEXICO DIGITAL PCR MARKET, BY APPLICATION, 2020-2028($MILLION)
  • TABLE 33.MEXICO DIGITAL PCR MARKET, BY END USER, 2020-2028($MILLION)
  • TABLE 34.NORTH AMERICA DIGITAL PCR MARKET, BY TECHNOLOGY, 2020-2028($MILLION)
  • TABLE 35.NORTH AMERICA DIGITAL PCR MARKET, BY PRODUCT TYPE, 2020-2028($MILLION)
  • TABLE 36.NORTH AMERICA DIGITAL PCR MARKET, BY APPLICATION, 2020-2028($MILLION)
  • TABLE 37.NORTH AMERICA DIGITAL PCR MARKET, BY END USER, 2020-2028($MILLION)
  • TABLE 38.EUROPE DIGITAL PCR MARKET, BY COUNTRY, 2020-2028($MILLION)
  • TABLE 39.GERMANY DIGITAL PCR MARKET, BY TECHNOLOGY, 2020-2028($MILLION)
  • TABLE 40.GERMANY DIGITAL PCR MARKET, BY PRODUCT TYPE, 2020-2028($MILLION)
  • TABLE 41.GERMANY DIGITAL PCR MARKET, BY APPLICATION, 2020-2028($MILLION)
  • TABLE 42.GERMANY DIGITAL PCR MARKET, BY END USER, 2020-2028($MILLION)
  • TABLE 43.FRANCE DIGITAL PCR MARKET, BY TECHNOLOGY, 2020-2028($MILLION)
  • TABLE 44.FRANCE DIGITAL PCR MARKET, BY PRODUCT TYPE, 2020-2028($MILLION)
  • TABLE 45.FRANCE DIGITAL PCR MARKET, BY APPLICATION, 2020-2028($MILLION)
  • TABLE 46.FRANCE DIGITAL PCR MARKET, BY END USER, 2020-2028($MILLION)
  • TABLE 47.UK DIGITAL PCR MARKET, BY TECHNOLOGY, 2020-2028($MILLION)
  • TABLE 48.UK DIGITAL PCR MARKET, BY PRODUCT TYPE, 2020-2028($MILLION)
  • TABLE 49.UK DIGITAL PCR MARKET, BY APPLICATION, 2020-2028($MILLION)
  • TABLE 50.UK DIGITAL PCR MARKET, BY END USER, 2020-2028($MILLION)
  • TABLE 51.ITALY DIGITAL PCR MARKET, BY TECHNOLOGY, 2020-2028($MILLION)
  • TABLE 52.ITALY DIGITAL PCR MARKET, BY PRODUCT TYPE, 2020-2028($MILLION)
  • TABLE 53.ITALY DIGITAL PCR MARKET, BY APPLICATION, 2020-2028($MILLION)
  • TABLE 54.ITALY DIGITAL PCR MARKET, BY END USER, 2020-2028($MILLION)
  • TABLE 55.SPAIN DIGITAL PCR MARKET, BY TECHNOLOGY, 2020-2028($MILLION)
  • TABLE 56.SPAIN DIGITAL PCR MARKET, BY PRODUCT TYPE, 2020-2028($MILLION)
  • TABLE 57.SPAIN DIGITAL PCR MARKET, BY APPLICATION, 2020-2028($MILLION)
  • TABLE 58.SPAIN DIGITAL PCR MARKET, BY END USER, 2020-2028($MILLION)
  • TABLE 59.REST OF EUROPE DIGITAL PCR MARKET, BY TECHNOLOGY, 2020-2028($MILLION)
  • TABLE 60.REST OF EUROPE DIGITAL PCR MARKET, BY PRODUCT TYPE, 2020-2028($MILLION)
  • TABLE 61.REST OF EUROPE DIGITAL PCR MARKET, BY APPLICATION, 2020-2028($MILLION)
  • TABLE 62.REST OF EUROPE DIGITAL PCR MARKET, BY END USER, 2020-2028($MILLION)
  • TABLE 63.EUROPE DIGITAL PCR MARKET, BY TECHNOLOGY, 2020-2028($MILLION)
  • TABLE 64.EUROPE DIGITAL PCR MARKET, BY PRODUCT TYPE, 2020-2028($MILLION)
  • TABLE 65.EUROPE DIGITAL PCR MARKET, BY APPLICATION, 2020-2028($MILLION)
  • TABLE 66.EUROPE DIGITAL PCR MARKET, BY END USER, 2020-2028($MILLION)
  • TABLE 67.ASIA-PACIFIC DIGITAL PCR MARKET, BY COUNTRY, 2020-2028($MILLION)
  • TABLE 68.JAPAN DIGITAL PCR MARKET, BY TECHNOLOGY, 2020-2028($MILLION)
  • TABLE 69.JAPAN DIGITAL PCR MARKET, BY PRODUCT TYPE, 2020-2028($MILLION)
  • TABLE 70.JAPAN DIGITAL PCR MARKET, BY APPLICATION, 2020-2028($MILLION)
  • TABLE 71.JAPAN DIGITAL PCR MARKET, BY END USER, 2020-2028($MILLION)
  • TABLE 72.CHINA DIGITAL PCR MARKET, BY TECHNOLOGY, 2020-2028($MILLION)
  • TABLE 73.CHINA DIGITAL PCR MARKET, BY PRODUCT TYPE, 2020-2028($MILLION)
  • TABLE 74.CHINA DIGITAL PCR MARKET, BY APPLICATION, 2020-2028($MILLION)
  • TABLE 75.CHINA DIGITAL PCR MARKET, BY END USER, 2020-2028($MILLION)
  • TABLE 76.AUSTRALIA DIGITAL PCR MARKET, BY TECHNOLOGY, 2020-2028($MILLION)
  • TABLE 77.AUSTRALIA DIGITAL PCR MARKET, BY PRODUCT TYPE, 2020-2028($MILLION)
  • TABLE 78.AUSTRALIA DIGITAL PCR MARKET, BY APPLICATION, 2020-2028($MILLION)
  • TABLE 79.AUSTRALIA DIGITAL PCR MARKET, BY END USER, 2020-2028($MILLION)
  • TABLE 80.INDIA DIGITAL PCR MARKET, BY TECHNOLOGY, 2020-2028($MILLION)
  • TABLE 81.INDIA DIGITAL PCR MARKET, BY PRODUCT TYPE, 2020-2028($MILLION)
  • TABLE 82.INDIA DIGITAL PCR MARKET, BY APPLICATION, 2020-2028($MILLION)
  • TABLE 83.INDIA DIGITAL PCR MARKET, BY END USER, 2020-2028($MILLION)
  • TABLE 84.SOUTH KOREA DIGITAL PCR MARKET, BY TECHNOLOGY, 2020-2028($MILLION)
  • TABLE 85.SOUTH KOREA DIGITAL PCR MARKET, BY PRODUCT TYPE, 2020-2028($MILLION)
  • TABLE 86.SOUTH KOREA DIGITAL PCR MARKET, BY APPLICATION, 2020-2028($MILLION)
  • TABLE 87.SOUTH KOREA DIGITAL PCR MARKET, BY END USER, 2020-2028($MILLION)
  • TABLE 88.TAIWAN DIGITAL PCR MARKET, BY TECHNOLOGY, 2020-2028($MILLION)
  • TABLE 89.TAIWAN DIGITAL PCR MARKET, BY PRODUCT TYPE, 2020-2028($MILLION)
  • TABLE 90.TAIWAN DIGITAL PCR MARKET, BY APPLICATION, 2020-2028($MILLION)
  • TABLE 91.TAIWAN DIGITAL PCR MARKET, BY END USER, 2020-2028($MILLION)
  • TABLE 92.REST OF ASIA-PACIFIC DIGITAL PCR MARKET, BY TECHNOLOGY, 2020-2028($MILLION)
  • TABLE 93.REST OF ASIA-PACIFIC DIGITAL PCR MARKET, BY PRODUCT TYPE, 2020-2028($MILLION)
  • TABLE 94.REST OF ASIA-PACIFIC DIGITAL PCR MARKET, BY APPLICATION, 2020-2028($MILLION)
  • TABLE 95.REST OF ASIA-PACIFIC DIGITAL PCR MARKET, BY END USER, 2020-2028($MILLION)
  • TABLE 96.ASIA-PACIFIC DIGITAL PCR MARKET, BY TECHNOLOGY, 2020-2028($MILLION)
  • TABLE 97.ASIA-PACIFIC DIGITAL PCR MARKET, BY PRODUCT TYPE, 2020-2028($MILLION)
  • TABLE 98.ASIA-PACIFIC DIGITAL PCR MARKET, BY APPLICATION, 2020-2028($MILLION)
  • TABLE 99.ASIA-PACIFIC DIGITAL PCR MARKET, BY END USER, 2020-2028($MILLION)
  • TABLE 100.LAMEA DIGITAL PCR MARKET, BY COUNTRY, 2020-2028($MILLION)
  • TABLE 101.BRAZIL DIGITAL PCR MARKET, BY TECHNOLOGY, 2020-2028($MILLION)
  • TABLE 102.BRAZIL DIGITAL PCR MARKET, BY PRODUCT TYPE, 2020-2028($MILLION)
  • TABLE 103.BRAZIL DIGITAL PCR MARKET, BY APPLICATION, 2020-2028($MILLION)
  • TABLE 104.BRAZIL DIGITAL PCR MARKET, BY END USER, 2020-2028($MILLION)
  • TABLE 105.SAUDI ARABIA DIGITAL PCR MARKET, BY TECHNOLOGY, 2020-2028($MILLION)
  • TABLE 106.SAUDI ARABIA DIGITAL PCR MARKET, BY PRODUCT TYPE, 2020-2028($MILLION)
  • TABLE 107.SAUDI ARABIA DIGITAL PCR MARKET, BY APPLICATION, 2020-2028($MILLION)
  • TABLE 108.SAUDI ARABIA DIGITAL PCR MARKET, BY END USER, 2020-2028($MILLION)
  • TABLE 109.SOUTH AFRICA DIGITAL PCR MARKET, BY TECHNOLOGY, 2020-2028($MILLION)
  • TABLE 110.SOUTH AFRICA DIGITAL PCR MARKET, BY PRODUCT TYPE, 2020-2028($MILLION)
  • TABLE 111.SOUTH AFRICA DIGITAL PCR MARKET, BY APPLICATION, 2020-2028($MILLION)
  • TABLE 112.SOUTH AFRICA DIGITAL PCR MARKET, BY END USER, 2020-2028($MILLION)
  • TABLE 113.REST OF LAMEA DIGITAL PCR MARKET, BY TECHNOLOGY, 2020-2028($MILLION)
  • TABLE 114.REST OF LAMEA DIGITAL PCR MARKET, BY PRODUCT TYPE, 2020-2028($MILLION)
  • TABLE 115.REST OF LAMEA DIGITAL PCR MARKET, BY APPLICATION, 2020-2028($MILLION)
  • TABLE 116.REST OF LAMEA DIGITAL PCR MARKET, BY END USER, 2020-2028($MILLION)
  • TABLE 117.LAMEA DIGITAL PCR MARKET, BY TECHNOLOGY, 2020-2028($MILLION)
  • TABLE 118.LAMEA DIGITAL PCR MARKET, BY PRODUCT TYPE, 2020-2028($MILLION)
  • TABLE 119.LAMEA DIGITAL PCR MARKET, BY APPLICATION, 2020-2028($MILLION)
  • TABLE 120.LAMEA DIGITAL PCR MARKET, BY END USER, 2020-2028($MILLION)
  • TABLE 121.4BASEBIO: COMPANY SNAPSHOT
  • TABLE 122.4BASEBIO: PRODUCT PORTFOLIO
  • TABLE 123.BIO-RAD: COMPANY SNAPSHOT
  • TABLE 124.BIO-RAD: OERATING SEGMENT
  • TABLE 125.BIO-RAD: PRODUCT PORTFOLIO
  • TABLE 126.BIO-RAD: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 127.COMBINATI: COMPANY SNAPSHOT
  • TABLE 128.COMBINATI: PRODUCT PORTFOLIO
  • TABLE 129.COMBINATI: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 130.FLUIDIGM: COMPANY SNAPSHOT
  • TABLE 131.FLUIDIGM: PRODUCT PORTFOLIO
  • TABLE 132.JN MEDSYS: COMPANY SNAPSHOT
  • TABLE 133.JN MEDSYS: PRODUCT PORTFOLIO
  • TABLE 134.MERCK: COMPANY SNAPSHOT
  • TABLE 135.MERCK: OPERATING SEGMENTS
  • TABLE 136.MERCK: PRODUCT PORTFOLIO
  • TABLE 137.QIAGEN: COMPANY SNAPSHOT
  • TABLE 138.QIAGEN: PRODUCT SEGMENT
  • TABLE 139.QIAGEN: PRODUCT PORTFOLIO
  • TABLE 140.SYSMEX: COMPANY SNAPSHOT
  • TABLE 141.SYSMEX: OERATING SEGMENT
  • TABLE 142.SYSMEX.: PRODUCT PORTFOLIO
  • TABLE 143.STILLA: COMPANY SNAPSHOT
  • TABLE 144.STILLA: PRODUCT PORTFOLIO
  • TABLE 145.THERMO FISHER: COMPANY SNAPSHOT
  • TABLE 146.THERMO FISHER.: OERATING SEGMENT
  • TABLE 147.THERMO FISHER.: PRODUCT PORTFOLIO

LIST OF FIGURES

  • FIGURE 01.SEGMENTATION OF GLOBAL DIGITAL POLYMERASE CHAIN REACTION MARKET
  • FIGURE 02.TOP INVESTMENT POCKETS, 2020
  • FIGURE 03.LOW BARGAINING POWER OF SUPPLIERS
  • FIGURE 04.MODERATE BARGAINING POWER OF BUYERS
  • FIGURE 05.HIGH THREAT OF SUBSTITUTION
  • FIGURE 06.LOW THREAT OF NEW ENTRANTS
  • FIGURE 07.MODERATE COMPETITIVE RIVALRY
  • FIGURE 08.GLOBAL DIGITAL POLYMERASE CHAIN REACTION MARKET: TOP PLAYER POSITIONING, 2020
  • FIGURE 09.GLOBAL DIGITAL POLYMERASE CHAIN REACTION MARKET: DRIVERS, RESTRAINTS, AND OPPORTUNITIES
  • FIGURE 10.COMPARATIVE SHARE ANALYSIS OF DROPLET DIGITAL POLYMERASE CHAIN REACTION MARKET, BY COUNTRY, 2020 & 2027 (%)
  • FIGURE 11.COMPARATIVE SHARE ANALYSIS OF CHIP BASED DIGITAL PCR MARKET, BY COUNTRY, 2020 & 2028 (%)
  • FIGURE 12.COMPARATIVE SHARE ANALYSIS OF BEAMING PCR MARKET, BY COUNTRY, 2020 & 2027 (%)
  • FIGURE 13.COMPARATIVE SHARE ANALYSIS OF DIGITAL POLYMERASE CHAIN REACTION MARKET FOR CONSUMABLES & REAGENTS, BY COUNTRY, 2020 & 2028 (%)
  • FIGURE 14.COMPARATIVE SHARE ANALYSIS OF DIGITAL PCR SYSTEMS MARKET, BY COUNTRY, 2020 & 2028 (%)
  • FIGURE 15.COMPARATIVE SHARE ANALYSIS OF DIGITAL POLYMERASE CHAIN REACTION MARKET FOR SOFTWARE & SERVICE, BY COUNTRY, 2020 & 2028 (%)
  • FIGURE 16.COMPARATIVE SHARE ANALYSIS OF DIGITAL POLYMERASE CHAIN REACTION MARKET FOR RESEARCH, BY COUNTRY, 2020 & 2028 (%)
  • FIGURE 17.COMPARATIVE SHARE ANALYSIS OF DIGITAL POLYMERASE CHAIN REACTION MARKET FOR CLINICAL DIAGNOSTICS, BY COUNTRY, 2020 & 2028 (%)
  • FIGURE 18.COMPARATIVE SHARE ANALYSIS OF DIGITAL POLYMERASE CHAIN REACTION MARKET FOR FORENSIC & OTHERS, BY COUNTRY, 2020 & 2028 (%)
  • FIGURE 19.COMPARATIVE SHARE ANALYSIS OF DIGITAL POLYMERASE CHAIN REACTION MARKET FOR CLINICAL DIAGNOSTIC LABORATORIES, BY COUNTRY, 2020 & 2028 (%)
  • FIGURE 20.COMPARATIVE SHARE ANALYSIS OF DIGITAL POLYMERASE CHAIN REACTION MARKET FOR PHARMACEUTICALS & BIOTECHNOLOGY INDUSTRIES, BY COUNTRY, 2020 & 2028
  • FIGURE 21.COMPARATIVE SHARE ANALYSIS OF DIGITAL POLYMERASE CHAIN REACTION MARKET FOR UNIVERSITIES & OTHER ORGANIZATIONS, BY COUNTRY, 2020 & 2028 (%)
  • FIGURE 22.4BASEBIO: NET SALES, 2017-2019 ($MILLION)
  • FIGURE 23.BIO-RAD: NET SALES, 2018-2020 ($MILLION)
  • FIGURE 24.BIO-RAD: REVENUE SHARE BY SEGMENT, 2020 (%)
  • FIGURE 25.BIO-RAD: REVENUE SHARE BY REGION, 2020 (%)
  • FIGURE 26.FLUIDIGM: NET SALES, 2018-2020 ($MILLION)
  • FIGURE 27.FLUIDIGM: REVENUE SHARE BY REGION, 2020 (%)
  • FIGURE 28.MERCK: NET SALES, 2018-2020 ($MILLION)
  • FIGURE 29.MERCK: REVENUE SHARE, BY SEGMENT, 2020 (%)
  • FIGURE 30.MERCK: REVENUE SHARE, BY REGION, 2020 (%)
  • FIGURE 31.QIAGEN: NET SALES, 2018-2020 ($MILLION)
  • FIGURE 32.QIAGEN: REVENUE SHARE, BY PRODUCT, 2020 (%)
  • FIGURE 33.QIAGEN: REVENUE SHARE, BY REGION, 2020 (%)
  • FIGURE 34.SYSMEX: NET SALES, 2018-2020 ($MILLION)
  • FIGURE 35.SYSMEX: REVENUE SHARE BY SEGMENT, 2020 (%)
  • FIGURE 36.SYSMEX: REVENUE SHARE BY REGION, 2020 (%)
  • FIGURE 37.THERMO FISHER: NET SALES, 2018-2020 ($MILLION)
  • FIGURE 38.THERMO FISHER: REVENUE SHARE BY SEGMENT, 2020 (%)
  • FIGURE 39.THERMO FISHER: REVENUE SHARE BY REGION, 2020 (%)
目次
Product Code: LI_18654 / A00532

The global digital polymerase chain reaction market generated $508.8 million in 2020, and is projected to reach $1,139.9 million by 2028, growing at a CAGR of 9.1% from 2021 to 2028.

Digital polymerase chain reaction (dPCR) is a new approach for the detection and quantification of nucleic acids that provides a sensitive and reproducible way to measure the amount of DNA or RNA present in a sample. dPCR exhibits high potential in the research (basic research and applied research), clinical diagnostics, forensics, and other similar arenas. dPCR systems are useful for copy number variation, rare sequence detection, mutation detection, miRNA analysis, gene expression analysis, and next-generation sequencing sample quantification.

The global digital polymerase chain reaction market is expected to register substantial growth in the near future, owing to rise in prevalence of infectious diseases and increase in awareness & acceptance of personalized medicines. In addition, advancements in the technique are anticipated to boost the market growth during the forecast period.

However, high cost of dPCR devices and reimbursement issues are the factors anticipated to hamper the market growth during the forecast period. Conversely, increase in funding for R&D activities is expected to offer remunerative opportunities for market players. The digital polymerase chain reaction market is segmented into technology, product type, application, end user, and region. By technology, the market is categorized into droplet digital PCR (ddPCR) and BEAMing digital PCR.

By technology, the market is bifurcated into droplet digital PCR (ddPCR), chip based digital PCR and BEAMing digital PCR. Depending on product type, it is fragmented into digital PCR systems, consumables & reagents, and software & services. On the basis of application, it is segregated into research, clinical diagnostics, and forensic & others. As per end user, it is differentiated into pharmaceuticals & biotechnology industries, clinical diagnostic laboratories, and universities & other organizations. Region wise, it is analyzed across North America (U.S., Canada, Mexico) Europe (Germany, France, UK, Italy, Spain, Rest of Europe) Asia-Pacific (Japan, China, Australia, India, South Korea, Taiwan and rest of Asia-Pacific) and LAMEA (Brazil, Saudi Arabia, South Africa, and Rest of LAMEA).

KEY BENEFITS FOR STAKEHOLDERS

  • This report entails a detailed quantitative analysis of the current market trends from 2020 to 2028 to identify prevailing opportunities along with strategic assessment of the global digital PCR market.
  • Market size and estimations are based on a comprehensive analysis of end users, developments, and services in the industry.
  • An in-depth analysis based on region assists to understand the regional market and facilitates strategic business planning.
  • Developmental strategies adopted by the key market players are enlisted to understand the competitive scenario of the market.

KEY MARKET SEGMENTS

By Technology

  • Droplet Digital PCR
  • Chip Based Digital PCR
  • BEAMing Digital PCR

By Product Type

  • Digital PCR Systems
  • Consumables & Reagents
  • Software & Services

By Application

  • Research
  • Clinical Diagnostics
  • Forensic & Others

By End User

  • Pharmaceuticals & Biotechnology Industries
  • Clinical Diagnostic Laboratories
  • Universities & Other Organizations

By Region

  • North America
  • U.S.
  • Canada
  • Mexico
  • Europe
  • Germany
  • France
  • UK
  • Italy
  • Spain
  • Rest of Europe
  • Asia-Pacific
  • Japan
  • China
  • Australia
  • India
  • South Korea
  • Taiwan
  • Rest of Asia-Pacific
  • LAMEA
  • Brazil
  • Saudi Arabia
  • South Africa
  • Rest of LAMEA

KEY MARKET PLAYERS

  • 4basebio AG
  • Bio-Rad Laboratories, Inc.
  • Combinati, Inc
  • Fluidigm Corporation
  • JN Medsys
  • Merck KGaA
  • Qiagen N.V
  • Stilla Technologies
  • Sysmex Corporation
  • Thermo Fisher Scientific, Inc.

TABLE OF CONTENTS

CHAPTER 1:INTRODUCTION

  • 1.1.Report description
  • 1.2.Key benefits for stakeholders
  • 1.3.Key market segments
  • 1.4.Research methodology
    • 1.4.1.Secondary research
    • 1.4.2.Primary research
    • 1.4.3.Analyst tools & models

CHAPTER 2:EXECUTIVE SUMMARY

  • 2.1.CXO perspective

CHAPTER 3:MARKET OVERVIEW

  • 3.1.Market definition and scope
  • 3.2.Key findings
    • 3.2.1.Top investment pockets
  • 3.3.Porter's five forces analysis
  • 3.4.Top player positioning, 2020
  • 3.5.Market dynamics
    • 3.5.1.Drivers
      • 3.5.1.1.Rise in prevalence of infectious diseases and cancer
      • 3.5.1.2.Increase in awareness and acceptance of personalized medicines
      • 3.5.1.3.Technological advancements
    • 3.5.2.Restraints
      • 3.5.2.1.High cost of dPCR devices
      • 3.5.2.2.Reimbursement issues
    • 3.5.3.Opportunity
      • 3.5.3.1.Increase in funding for R&D activities
  • 3.6.NGS technology Impact on Digital PCR Market
  • 3.7.Impact analysis of COVID-19 on the digital PCR market

CHAPTER 4:DIGITAL POLYMERASE CHAIN REACTION MARKET, BY TECHNOLOGY

  • 4.1.Overview
    • 4.1.1.Market size and forecast
    • 4.1.2.Market size and forecast for PCR Market, 2017-2023
  • 4.2.Droplet digital PCR
    • 4.2.1.Key market trends, growth factors, and opportunities
    • 4.2.2.Market size and forecast
    • 4.2.3.Market analysis, by country
  • 4.3.Chip based digital PCR
    • 4.3.1.Key market trends, growth factors, and opportunities
    • 4.3.2.Market size and forecast
    • 4.3.3.Market analysis, by country
  • 4.4.BEAMing dPCR
    • 4.4.1.Key market trends, growth factors, and opportunities
    • 4.4.2.Market size and forecast
    • 4.4.3.Market analysis, by country

CHAPTER 5:DIGITAL POLYMERASE CHAIN REACTION MARKET, BY PRODUCT TYPE

  • 5.1.Overview
    • 5.1.1.Market size and forecast
  • 5.2.Consumables & reagents
    • 5.2.1.Market size and forecast
    • 5.2.2.Market analysis, by country
  • 5.3.Digital PCR systems
    • 5.3.1.Market size and forecast
    • 5.3.2.Market analysis, by country
  • 5.4.Software & services
    • 5.4.1.Market size and forecast
    • 5.4.2.Market analysis, by country

CHAPTER 6:DIGITAL POLYMERASE CHAIN REACTION MARKET, BY APPLICATION

  • 6.1.Overview
    • 6.1.1.Market size and forecast
  • 6.2.Research
    • 6.2.1.Market size and forecast
    • 6.2.2.Market analysis, by country
  • 6.3.Clinical diagnostics
    • 6.3.1.Market size and forecast
    • 6.3.2.Market analysis, by country
  • 6.4.Forensic & others
    • 6.4.1.Market size and forecast
    • 6.4.2.Market analysis, by country

CHAPTER 7:DIGITAL POLYMERASE CHAIN REACTION MARKET, BY END USER

  • 7.1.Overview
    • 7.1.1.Market size and forecast
  • 7.2.Clinical diagnostic laboratories
    • 7.2.1.Market size and forecast
    • 7.2.2.Market analysis, by country
  • 7.3.Pharmaceuticals & biotechnology industries
    • 7.3.1.Market size and forecast
    • 7.3.2.Market analysis, by country
  • 7.4.Universities & other organizations
    • 7.4.1.Market size and forecast
    • 7.4.2.Market analysis, by country

CHAPTER 8:DIGITAL POLYMERASE CHAIN REACTION MARKET, BY REGION

  • 8.1.Overview
    • 8.1.1.Market size and forecast
  • 8.2.North America
    • 8.2.1.Key market trends and opportunities
    • 8.2.2.North America digital PCR market, by country
      • 8.2.2.1.U.S. digital PCR market, by technology
      • 8.2.2.2.U.S. digital PCR market, by product type
      • 8.2.2.3.U.S. digital PCR market, by application
      • 8.2.2.4.U.S. digital PCR market, by end user
      • 8.2.2.5.Canada digital PCR market, by technology
      • 8.2.2.6.Canada digital PCR market, by product type
      • 8.2.2.7.Canada digital PCR market, by application
      • 8.2.2.8.Canada digital PCR market, by end user
      • 8.2.2.9.Mexico digital PCR market, by technology
      • 8.2.2.10.Mexico digital PCR market, by product type
      • 8.2.2.11.Mexico digital PCR market, by application
      • 8.2.2.12.Mexico digital PCR market, by end user
    • 8.2.3.North America digital PCR market, by technology
    • 8.2.4.North America digital PCR market, by product type
    • 8.2.5.North America digital PCR market, by application
    • 8.2.6.North America digital PCR market, by end user
  • 8.3.Europe
    • 8.3.1.Key market trends and opportunities
    • 8.3.2.Europe digital PCR market, by country
      • 8.3.2.1.Germany digital PCR market, by technology
      • 8.3.2.2.Germany digital PCR market, by product type
      • 8.3.2.3.Germany digital PCR market, by application
      • 8.3.2.4.Germany digital PCR market, by end user
      • 8.3.2.5.France digital PCR market, by technology
      • 8.3.2.6.France digital PCR market, by product type
      • 8.3.2.7.France digital PCR market, by application
      • 8.3.2.8.France digital PCR market, by end user
      • 8.3.2.9.UK digital PCR market, by technology
      • 8.3.2.10.UK digital PCR market, by product type
      • 8.3.2.11.UK digital PCR market, by application
      • 8.3.2.12.UK digital PCR market, by end user
      • 8.3.2.13.Italy digital PCR market, by technology
      • 8.3.2.14.Italy digital PCR market, by product type
      • 8.3.2.15.Italy digital PCR market, by application
      • 8.3.2.16.Italy digital PCR market, by end user
      • 8.3.2.17.Spain digital PCR market, by technology
      • 8.3.2.18.Spain digital PCR market, by product type
      • 8.3.2.19.Spain digital PCR market, by application
      • 8.3.2.20.Spain digital PCR market, by end user
      • 8.3.2.21.Rest of Europe digital PCR market, by technology
      • 8.3.2.22.Rest of Europe digital PCR market, by product type
      • 8.3.2.23.Rest of Europe digital PCR market, by application
      • 8.3.2.24.Rest of Europe digital PCR market, by end user
    • 8.3.3.Europe digital PCR market, by technology
    • 8.3.4.Europe digital PCR market, by product type
    • 8.3.5.Europe digital PCR market, by application
    • 8.3.6.Europe digital PCR market, by end user
  • 8.4.Asia-Pacific
    • 8.4.1.Key market trends and opportunities
    • 8.4.2.Asia-Pacific digital PCR market, by country
      • 8.4.2.1.Japan digital PCR market, by technology
      • 8.4.2.2.Japan digital PCR market, by product type
      • 8.4.2.3.Japan digital PCR market, by application
      • 8.4.2.4.Japan digital PCR market, by end user
      • 8.4.2.5.China digital PCR market, by technology
      • 8.4.2.6.China digital PCR market, by product type
      • 8.4.2.7.China digital PCR market, by application
      • 8.4.2.8.China digital PCR market, by end user
      • 8.4.2.9.Australia digital PCR market, by technology
      • 8.4.2.10.Australia digital PCR market, by product type
      • 8.4.2.11.Australia digital PCR market, by application
      • 8.4.2.12.Australia digital PCR market, by end user
      • 8.4.2.13.India digital PCR market, by technology
      • 8.4.2.14.India digital PCR market, by product type
      • 8.4.2.15.India digital PCR market, by application
      • 8.4.2.16.India digital PCR market, by end user
      • 8.4.2.17.South Korea digital PCR market, by technology
      • 8.4.2.18.South Korea digital PCR market, by product type
      • 8.4.2.19.South Korea digital PCR market, by application
      • 8.4.2.20.South Korea digital PCR market, by end user
      • 8.4.2.21.Taiwan digital PCR market, by technology
      • 8.4.2.22.Taiwan digital PCR market, by product type
      • 8.4.2.23.Taiwan digital PCR market, by application
      • 8.4.2.24.Taiwan digital PCR market, by end user
      • 8.4.2.25.Rest of Asia-Pacific digital PCR market, by technology
      • 8.4.2.26.Rest of Asia-Pacific digital PCR market, by product type
      • 8.4.2.27.Rest of Asia-Pacific digital PCR market, by application
      • 8.4.2.28.Rest of Asia-Pacific digital PCR market, by end user
    • 8.4.3.Asia-Pacific digital PCR market, by technology
    • 8.4.4.Asia-Pacific digital PCR market, by product type
    • 8.4.5.Asia-Pacific digital PCR market, by application
    • 8.4.6.Asia-Pacific digital PCR market, by end user
  • 8.5.LAMEA
    • 8.5.1.Key market trends and opportunities
    • 8.5.2.LAMEA digital PCR market, by country
      • 8.5.2.1.Brazil digital PCR market, by technology
      • 8.5.2.2.Brazil digital PCR market, by product type
      • 8.5.2.3.Brazil digital PCR market, by application
      • 8.5.2.4.Brazil digital PCR market, by end user
      • 8.5.2.5.Saudi Arabia digital PCR market, by technology
      • 8.5.2.6.Saudi Arabia digital PCR market, by product type
      • 8.5.2.7.Saudi Arabia digital PCR market, by application
      • 8.5.2.8.Saudi Arabia digital PCR market, by end user
      • 8.5.2.9.South Africa digital PCR market, by technology
      • 8.5.2.10.South Africa digital PCR market, by product type
      • 8.5.2.11.South Africa digital PCR market, by application
      • 8.5.2.12.South Africa digital PCR market, by end user
      • 8.5.2.13.Rest of LAMEA digital PCR market, by technology
      • 8.5.2.14.Rest of LAMEA digital PCR market, by product type
      • 8.5.2.15.Rest of LAMEA digital PCR market, by application
      • 8.5.2.16.Rest of LAMEA digital PCR market, by end user
    • 8.5.3.LAMEA digital PCR market, by technology
    • 8.5.4.LAMEA digital PCR market, by product type
    • 8.5.5.LAMEA digital PCR market, by application
    • 8.5.6.LAMEA digital PCR market, by end user

CHAPTER 9:COMPANY PROFILES

  • 9.1.4BASEBIO AG
    • 9.1.1.Company overview
    • 9.1.2.Company snapshot
    • 9.1.3.Operating business segments
    • 9.1.4.Product portfolio
    • 9.1.5.Business Performance
  • 9.2.BIO-RAD LABORATORIES, INC.
    • 9.2.1.Company overview
    • 9.2.2.Company snapshot
    • 9.2.3.Operating business segments
    • 9.2.4.Product portfolio
    • 9.2.5.Business performance
    • 9.2.6.Key strategic moves and developments
  • 9.3.COMBINATI, INC.
    • 9.3.1.Company overview
    • 9.3.2.Company snapshot
    • 9.3.3.Operating business segments
    • 9.3.4.Product portfolio
    • 9.3.5.Key strategic moves and developments
  • 9.4.FLUIDIGM CORPORATION
    • 9.4.1.Company overview
    • 9.4.2.Company snapshot
    • 9.4.3.Operating business segments
    • 9.4.4.Product portfolio
    • 9.4.5.Business performance
  • 9.5.JN MEDSYS
    • 9.5.1.Company overview
    • 9.5.2.Company snapshot
    • 9.5.3.Product portfolio
    • 9.5.4.Key strategic moves and developments
  • 9.6.MERCK KGAA
    • 9.6.1.Company overview
    • 9.6.2.Company snapshot
    • 9.6.3.Operating business segments
    • 9.6.4.Product portfolio
    • 9.6.5.Business performance
    • 9.6.6.Key strategic moves and developments
  • 9.7.QIAGEN N.V.
    • 9.7.1.Company overview
    • 9.7.2.Company snapshot
    • 9.7.3.Operating business segment
    • 9.7.4.Product portfolio
    • 9.7.5.Business performance
    • 9.7.6.Key strategic moves and developments
  • 9.8.SYSMEX CORPORATION
    • 9.8.1.Company overview
    • 9.8.2.Company snapshot
    • 9.8.3.Operating business segments
    • 9.8.4.Product portfolio
    • 9.8.5.Business performance
  • 9.9.STILLA TECHNOLOGIES
    • 9.9.1.Company overview
    • 9.9.2.Company snapshot
    • 9.9.3.Product portfolio
    • 9.9.4.Key strategic moves and developments
  • 9.10.THERMO FISHER SCIENTIFIC, INC.
    • 9.10.1.Company overview
    • 9.10.2.Company snapshot
    • 9.10.3.Operating business segments
    • 9.10.4.Product portfolio
    • 9.10.5.Business performance